Biotech

All Articles

ReNeuron leaving goal swap after missing out on fundraising objective

.ReNeuron has actually joined the lengthy checklist of biotechs to leave London's AIM stock exchange...

MBX files for IPO to take opposition to Ascendis into stage 3

.MBX Biosciences has added to the recent outbreak of IPO filings. The biotech, which submitted its o...

FDA broadens probe right into Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and also the company's prospective MDMA-assisted treatment for trauma (PTSD)...

Gene publisher Volume laying off 131 workers

.Only times after gene editor Volume Biosciences declared concealed functional slices, a more clear ...

Repare lays off 25% of personnel as biotech standstills preclinical R&ampD

.Repare Therapy is laying off an one-fourth of its own workforce as the oncology biotech scales back...

J &amp J files for FDA authorization of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten an additional measure towards recognizing a gain on its $6...

Gain's phase 1 gain paves means to confirm Parkinson's medication's worth

.Increase Therapeutics has actually prepared its own sights on verifying the efficiency of its Parki...

Actinogen documents new stage 2 data to save anxiety medication

.Actinogen Medical's chances-- and supply cost-- have actually rebounded a little coming from earlie...

Pfizer and Flagship add Ratio to multibillion-dollar formula

.Front Runner Pioneering and also Pfizer have incorporated Ratio into their 10-program partnership, ...

Bayer pens $547M contract to push borders of noncoding RNA

.Bayer executives were actually eager to tension to Fierce this summer that the German pharma titan'...